Hepatitis C Virus (HCV) Direct-Acting Antiviral Therapy in Persons With Human Immunodeficiency Virus–HCV Genotype 1 Coinfection Resulting in High Rate of Sustained Virologic Response and Variable in Normalization of Soluble Markers of Immune Activation

BACKGROUND: Hepatitis C virus (HCV) direct-acting antivirals are highly effective. Less is known about changes in markers of immune activation in persons with human immunodeficiency virus (HIV) in whom a sustained virologic response (SVR) is achieved. METHODS: We conducted a nonrandomized clinical t...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Infect Dis
Autori principali: Anthony, Donald D, Sulkowski, Mark S, Smeaton, Laura M, Damjanovska, Sofi, Shive, Carey L, Kowal, Corinne M, Cohen, Daniel E, Bhattacharya, Debika, Alston-Smith, Beverly L, Balagopal, Ashwin, Wyles, David L
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2020
Soggetti:
Major Articles and Brief Reports
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7749191/
https://ncbi.nlm.nih.gov/pubmed/32406487
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiaa254
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi